The document discusses the development of nutraceuticals targeting cancer, specifically focusing on natural extracts rich in compounds like perillyl alcohol (poh) from sweet cherries and polymethoxylated flavones (pmf) from citrus peels. It highlights the potential of these extracts to inhibit cancer cell growth and induce apoptosis in colorectal cancer cell lines (HT29) when used in conjunction with chemotherapy drugs. Several processes for extraction and characterization of these compounds are described, utilizing high-pressure technology and supercritical fluid methods.